3185 results for «308»

Filter By

3185 results

Transcatheter electrosurgery and leaflet modification of the aortic valve

15 Feb 2026 – From PCR Tokyo Valves 2026

Focused on advanced transcatheter leaflet modification techniques, this session explores indications and patient selection for TAV-in-SAV cases in Asian populations. It details the concepts, procedural setup, and material preparation for transcatheter electrosurgery, with in-depth coverage of BASILICA and UNICORN techniques, including step-by-step guidance, recorded cases, troubleshooting,...

Prognostic significance of thermodilution-derived coronary flow capacity in patients with deferred revascularisation

15 Mar 2021

The aim of this study was to investigate the prognostic value of thermodilution-derived coronary flow capacity (T-CFC) in patients with stable coronary artery disease and deferred revascularisation.

Authors :

Masahiro Hoshino, Yoshihisa Kanaji, Rikuta Hamaya, Yoshinori Kanno, Masahiro Hada, Masao Yamaguchi, Yohei Sumino, Eisuke Usui, Tadashi Murai, Tetsumin Lee, Taishi Yonetsu, Tsunekazu Kakuta
EuroIntervention: Prognostic significance of thermodilution-derived coronary flow capacity in patients with deferred revascularisation

Jupiter Endovascular announces positive results from SPIRARE I first-in-human study presented at TCT 2025

26 Oct 2025

SURTAVI: five-year results from a randomized trial of TAVR vs. SAVR in patients at intermediate surgical risk

07 Nov 2021

Although TAVI is an accepted alternative to surgery in patients with severe aortic stenosis who are at high surgical risk, less is known about long-term comparative outcomes among patients with aortic stenosis who are at intermediate surgical risk. P. Redaelli & M. Pighi review the SURTAVI trial...

Paola Redaelli

Author

Paola Redaelli
M. Pighi

Author

Michele Pighi
SURTAVI: five-year results from a randomized trial of TAVR vs. SAVR in patients at intermediate surgical risk

NEO-MINDSET: Early withdrawal of aspirin after percutaneous coronary intervention for acute coronary syndrome

02 Sep 2025

Daniele Giacoppo reports and provides his perspective on the main results of the ambitious NEOMINDSET trial, presented by Pedro Lemos from the Hospital Israelita Albert Einstein, São Paulo, Brazil, during a Late Breaking Trials session at the ESC Congress 2025 in Madrid, and simultaneously published in the New...

Daniele Giacoppo

Author

Daniele Giacoppo
NEO-MINDSET: Early withdrawal of aspirin after percutaneous coronary intervention for acute coronary syndrome
Didn’t find what you were looking for?